BioCentury
ARTICLE | Financial News

argenx, Proteostasis, Dicerna raise follow-ons

December 14, 2017 9:12 PM UTC

Antibody company argenx S.E. (Euronext:ARGX; NASDAQ:ARGX), respiratory company Proteostasis Therapeutics Inc. (NASDAQ:PTI) and RNA therapeutics play Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) raised a combined $311 million in follow-on offerings.

argenx raised $231 million through the sale of 4.4 million ADSs at $52 in a bumped-up follow-on underwritten by Cowen, Piper Jaffray, JMP Securities and Wedbush PacGrow. The price is a 5% discount to argenx’s NASDAQ close of $54.47 on Monday, when it proposed after market hours to raise $150 million. Each ADS represents one ordinary share...